We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Secondary Hyperparathyroidism in Chronic Renal Disease

John T. Potts, MD; Richard E. Reitz, MD; Leonard J. Deftos, MD; Michael B. Kaye, MD, FRCP; James A. Richardson, MD; Richard M. Buckle, MD; Gerald D. Aurbach, MD
Arch Intern Med. 1969;124(4):408-412. doi:10.1001/archinte.1969.00300200020003.
Text Size: A A A
Published online


Secondary hyperparathyroidism is a metabolic state characterized by an excessive but not autonomous rate of production of parathyroid hormone: this disorder is encountered invariably in chronic renal failure and also in other disease states where there is resistance to the metabolic actions of parathyroid hormone.1 The resistance to the biological effects of the hormone lead, through mechanisms as yet unclarified, to hyperplasia of the parathyroids. For many years secondary hyperparathyroidism had been postulated to be present in patients with chronic renal disease.2 It was known from postmortem studies of patients with renal failure that the parathyroids were hyperplastic; in addition, changes typical of osteitis fibrosa were found in many patients with far advanced renal failure, as discussed elsewhere in this symposium by Stanbury and others. Studies with the radioimmunoassay by Berson and Yalow, Reiss (reviewed in this symposium), and us have now confirmed that there is an increased concentration of


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.